HUM-MOLGEN events: bioLOGIC Asia 2002

HUM-MOLGEN -> Events -> Meetings and Conferences

bioLOGIC Asia 2002

July 15, 2002

Terrapinn Pte Ltd, Singapore
19-21 November 2002

bioLOGIC Asia 2002 conference is the only event in Asia Pacific that addresses manufacturing and scale-up solutions for the biologics manufacturing industry. Coming to Asia for the first time, this dedicated conference will be addressing site selection, government initiatives, outsourcing, process development and contract manufacturing issues for your industry. In just 3 days, you will be meeting the various representative bodies in Asia Pacific who will be sharing the insights to biotech / pharma developments and investments and consultants and financiers who can advise on your next plant location and expansion.

You will be learning and sharing with fellow biotech / pharma professionals from Asia Pacific and beyond. You can also expect lots of networking opportunities with potential partnerships and alliances that might come through.

 The future of biotechnology in Asia Pacific
 Can Asia Pacific meet the growing demand for manufacturing facilities for biologics?
 Examining government initiatives in Asia Pacific to encourage foreign investments
 Dealing with capacity crunch in biopharma
 Country and site selection for a flexible manufacturing strategy
 Process optimisation and novel techniques to intensify downstream processing
 Maximising the strategic value of your in house Vs outsource decision
 Integrating scale-up into your R&D strategy and building a value-add development process
 Selecting and management contract manufacturers

Organized by:

Terrapinn

Invited Speakers:

 Dr S Natesh, Adviser and Member Secretary, National Bioresource Development Board, Department of Biotechnology, Government of India
 Dr Gurinder Shahi, Chairman and CEO, BioEnterprise Asia, Singapore
 Dr Hiu Ming Pang, CEO, World Pioneer Limited & Director, E2-Captial BioTech Advisory Group, Hong Kong
 Dr Makarand Jawadekar, Assistant Director, Pharmaceutical Science Operations & Strategic External Alliance Management, Pfizer Global R & D, Groton
 Peter Ketelaar, Director of New Business Development, DSM Biologics
 Prof Rolf Werner, Head of Corporate Division, Biopharmaceuticals, Boehringer Ingelheim
 Stephen Runnels, CEO, S*Bio
 Richard Piazza, President & CEO, VitaGen
 Dr Shawn Leung, Managing Director, Hong Kong Institute of Biotechnology
 Edmund Tung, Development Center for Biotechnology, Taiwan
 Dr Joseph Santangelo, Associate Director, Process Formulation and Development, Microscience
 Richard Reidinger, Deputy Managing Director, Environmental Resources Management Singapore
 Stan Yakatan, Deputy Chair, Biocomm International & Chairman and Managing Partner, Katan Associates

Deadline for Abstracts:

n.a.

Registration:

www.pharma-rd.net/biologicAsia2002

E-mail:

stephanie.tan@terrapinn.com

Posted by:

Stephanie Tan

Host:

203.126.60.142